GLSI Insider Transactions — Page 2
122 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–122; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Hallock Kenneth | Director | 2022-01-21 | Purchase | 300.0 | $16.32 |
| Thompson Jaye | VP Clinical Reg. Affairs | 2022-01-18 | Purchase | 500.0 | $18.87 |
| Patel Snehal | CEO and CFO | 2022-01-13 | Purchase | 1,000.0 | $19.99 |
| Thompson Jaye | VP Clinical Reg. Affairs | 2022-01-13 | Purchase | 1,000.0 | $19.99 |
| Daugherty Frank Joseph | Chief Medical Officer | 2022-01-13 | Purchase | 1,000.0 | $19.99 |
| Patel Snehal | CEO and CFO | 2022-01-03 | Purchase | 2,050.0 | $23.82 |
| Patel Snehal | CEO and CFO | 2021-12-14 | Purchase | 1,840.0 | $27.17 |
| Daugherty Frank Joseph | Chief Medical Officer | 2021-12-14 | Purchase | 1,111.0 | $26.99 |
| McWilliams David | Director | 2021-12-14 | Purchase | 200.0 | $27.56 |
| Patel Snehal | CEO and CFO | 2021-04-13 | Purchase | 2,700.0 | $36.98 |
| Hallock Kenneth | Director | 2020-11-24 | Purchase | 1,000.0 | $5.39 |
| Daugherty Frank Joseph | Chief Medical Officer | 2020-11-23 | Purchase | 1,000.0 | $5.1 |
| Hallock Kenneth | Director | 2020-11-20 | Purchase | 1,000.0 | $5.37 |
| McWilliams David | Director | 2020-11-20 | Purchase | 1,500.0 | $5.4 |
| Rothe Eric | Director | 2020-11-20 | Purchase | 2,000.0 | $5.4 |
| Patel Snehal | CEO and CFO | 2020-11-19 | Purchase | 2,000.0 | $5.4 |
| Patel Snehal | CEO and CFO | 2020-09-29 | Purchase | 16,667.0 | $4.6 |
| Hallock Kenneth | Director | 2020-09-29 | Purchase | 8,333.0 | $4.6 |
| Hallock Kenneth | Director | 2020-09-29 | Purchase | 74,782.0 | $5.75 |
| Patel Snehal | CEO and CFO | 2020-09-29 | Purchase | 114,347.0 | $5.75 |
| Daugherty Frank Joseph | Chief Medical Officer | 2020-09-29 | Purchase | 1,739.0 | $5.75 |
| McWilliams David | Director | 2020-09-29 | Purchase | 2,608.0 | $5.75 |